ClinicalTrials.gov
public full text
Public Domain
An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
A multicentre, interventional, multi-arm, multi-stage Phase 3 trial including randomisation, double blinding, placebo control evaluation of treatments for sustained clinical response (18 months) in symptomatic Alzheimer's Disease in a population representative of people with Alzheimer's disease in the UK.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease#915777
- Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention#1352221
- Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease#1211107
- Alzheimer's Disease Multiple Intervention Trial#1008264
- Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)#890991
Record · ID 1421882
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive